Author

Morgan Overstreet

Institution: Medical University of South Carolina

Observed institution: Medical University of South Carolina

ORCID: 0009-0001-7165-7689

Observed ORCID: 0009-0001-7165-7689

OpenAlex ID: A5113584809

Muscle inflammation is regulated by NF-κB from multiple cells to control distinct states of wasting in cancer cachexia

2024 · Benjamin R. Pryce, Alexander Oles, et al. · Cell Reports · 56

Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation

2024 · Karim Soliman, Isabel K. Calimlim, et al. · Transplant Infectious Disease · 11

Alpha-1 Antitrypsin Augmentation Therapy in Chronic Pancreatitis Patients Undergoing Total Pancreatectomy and Islet Autotransplantation: A Randomized, Controlled Study

2024 · Hongjun Wang, Wenyu Gou, et al. · Cell Transplantation · 4

Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT Study): Protocol for a Randomized Controlled Trial

2024 · Morgan Overstreet, Hannah Culpepper, et al. · JMIR Research Protocols · 2

Secular trends in cytomegalovirus (CMV) risk and outcomes: results from a 10-year longitudinal cohort study in adult kidney transplant recipients

2025 · Amy Perry, Karim Soliman, et al. · International Urology and Nephrology · 1

Results of a Randomized Controlled Trial Evaluating the Impact of Conversion to LCP Tacrolimus on Neurologic Toxicities in Liver Transplant Recipients

2025 · Kelsey S. Coffman, Gonzalo J. Revuelta, et al. · International Journal of Hepatology · 1

P3.648: Early graft outcomes following fluid restrictions in postoperative care of kidney transplant.

2026 · Deanna DeHoff, Abhijith Nair, et al. · Transplantation

Single-center, open-label, randomized controlled trial comparing the tolerability of maribavir 400 mg twice daily versus standard-dose valganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

2026 · David J. Taber, Hannah Culpepper, et al. · American Journal of Transplantation

A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for Cytomegalovirus (CMV) Prophylaxis in High-Risk Kidney Transplant Recipients: Study Protocol

2025 · Hannah Culpepper, Morgan Overstreet, et al. · Cureus

Secular trends in cytomegalovirus risk and outcomes by race: A 10-year longitudinal study in adult kidney transplant recipients

2025 · Karim Soliman, Ahmed Daoud, et al. · Journal of Clinical and Translational Research

A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Study Protocol (Maribavir IIR)

2024 · Hannah Culpepper, Morgan Overstreet, et al. · Research Square

Works count: 11

Citation count: 74

H-index: 3

I10-index: 2